Evaluation of gonorrhea test of cure at 1 week in a los angeles community-based clinic serving men who have sex with men

Sexually Transmitted Diseases

Volumn 41, Issue 10, 2014, Pages 595-600

  Beymer, Matthew R ^a,b   Llata, Eloisa ^c   Stirland, Ali M ^d   Weinstock, Hillard S ^c   Wigen, Christine L ^d   Guerry, Sarah L ^d   Mejia, Everardo ^a   Bolan, Robert K ^a  

^a LOS ANGELES LGBT CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d Los Angeles County Department of Public Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CEFTRIAXONE;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; COMMUNITY HOSPITAL; DEMOGRAPHY; DIAGNOSTIC PROCEDURE; DYSURIA; FOLLOW UP; GONORRHEA; HEALTH CARE FACILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEN WHO HAVE SEX WITH MEN; NEISSERIA GONORRHOEAE; NUCLEIC ACID AMPLIFICATION; PHARYNX; RECTUM; RECTUM DISEASE; SEXUAL BEHAVIOR; SINGLE DRUG DOSE; TEST OF CURE; TREATMENT DURATION; URETHRA; URETHRAL DISCHARGE; ADOLESCENT; ANTIBIOTIC RESISTANCE; DRUG EFFECTS; EVALUATION STUDY; ISOLATION AND PURIFICATION; MALE HOMOSEXUALITY; MASS SCREENING; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT SATISFACTION; PHARYNGEAL DISEASES; RECTAL DISEASES; SENTINEL SURVEILLANCE; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; TIME; UNITED STATES;

ADOLESCENT; ADULT; AZITHROMYCIN; CEFTRIAXONE; DRUG RESISTANCE, BACTERIAL; FOLLOW-UP STUDIES; GONORRHEA; HOMOSEXUALITY, MALE; HUMANS; LOGISTIC MODELS; LOS ANGELES; MALE; MASS SCREENING; MIDDLE AGED; NEISSERIA GONORRHOEAE; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PATIENT COMPLIANCE; PATIENT SATISFACTION; PHARYNGEAL DISEASES; RECTAL DISEASES; SENTINEL SURVEILLANCE; SEXUAL BEHAVIOR; TIME FACTORS;

EID: 84914161384     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/OLQ.0000000000000190     Document Type: Article

References (28)

1. Centers for Disease Control and Prevention. 2011 Sexually transmitted diseases surveillance - Gonorrhea [CDC Web site]. December 13, 2012. Available at: http://www.cdc.gov/std/stats11/gonorrhea.htm. Accessed September 1, 2013.
2. Newman LM, Dowell D, Bernstein K, et al. A tale of two gonorrhea epidemics: Results from the STD Surveillance Network. Public Health Rep 2012; 127: 282-292.
3. Kent CK, Chaw JK, Wong W, et al. Prevalence of rectal, urethral, and pharyngeal chlamydia and gonorrhea detected in 2 clinical settings among men who have sex with men: San Francisco, California, 2003. Clin Infect Dis 2005; 41: 67-74.
4. Morris SR, Klausner JD, Buchbinder SP, et al. Prevalence and incidence of pharyngeal gonorrhea in a longitudinal sample of men who have sex with men: The EXPLORE study. Clin Infect Dis 2006; 43: 1284-1289.
5. Boyadzhyan B, Yashina T, Patnaik M, et al. Comparison of the APTIMA CT and GC assays with the APTIMA combo 2 assay, the Abbott LCx assay, and direct fluorescent-antibody and culture assays for detection of Chlamydia trachomatis and Neisseria gonorrhoeae. J Clin Microbiol 2004; 42: 3089-3093.
6. Bachmann LH, Johnson RE, Cheng H, et al. Nucleic acid amplification tests for diagnosis of Neisseria gonorrhoeae oropharyngeal infections. J Clin Microbiol 2009; 47: 902-907.
7. Bachmann LH, Johnson RE, Cheng H, et al. Nucleic acid amplification tests for diagnosis of Neisseria gonorrhoeae and Chlamydia trachomatis rectal infections. J Clin Microbiol 2010; 48: 1827-1832.
8. Klausner JD, Bernstein KT, Pandori M, et al. Clinic-based testing for rectal and pharyngeal Neisseria gonorrhoeae and Chlamydia trachomatis infections by community-based organizations - Five cities, United States, 2007. MMWR Morb Mortal Wkly Rep 2009; 58: 716-719.
9. Allen VG, Mitterni L, Seah C, et al. Neisseria gonorrhoeae treatment failure and susceptibility to cefixime in Toronto, Canada. JAMA 2013; 309: 163-170.
10. Del Rio C, Hall G, Hook EW, et al. Update to CDC's sexually transmitted diseases treatment guidelines, 2006: Fluoroquinolones no longer recommended for treatment of gonococcal infections. MMWR Morb Mortal Wkly Rep 2007; 56: 332-336.
11. Del Rio C, Hall G, Holmes K, et al. Update to CDC's sexually transmitted diseases treatment guidelines, 2010: Oral cephalosporins no longer a recommended treatment for gonococcal infections. MMWR Morb Mortal Wkly Rep 2012; 61: 590-594.
12. Lewis DA, Lukehart SA. Antimicrobial resistance in Neisseria gonorrhoeae and Treponema pallidum: Evolution, therapeutic challenges and the need to strengthen global surveillance. Sex Transm Infect. 2011; 87: ii39-ii43.
13. Ohnishi M, Saika T, Hoshina S, et al. Ceftriaxone-resistant Neisseria gonorrhoeae, Japan. Emerg Infect Dis 2011; 17: 148-149.
14. Del Rio C, Hall G, Hook EW, et al. Cephalosporin susceptibility among Neisseria gonorrhoeae isolates - United States, 2000-2010. MMWR Morb Mortal Wkly Rep 2011; 60: 873-877.
15. Bachmann LH, Desmond RA, Stephens J, et al. Duration of persistence of gonococcal DNA detected by ligase chain reaction in men and women following recommended therapy for uncomplicated gonorrhea. J Clin Microbiol 2002; 40: 3596-3601.
16. Hjelmevoll SO, Olsen ME, Sollid JU, et al. Appropriate time for test-of-cure when diagnosing gonorrhoea with a nucleic acid amplification test. Acta Derm Venereol 2012; 92: 316-319.
17. Centers for Disease Control and Prevention. Defining Public Health research and Public Health Non-research [CDC Web site]. July 29, 2010. Available at: http://www.cdc.gov/od/science/integrity/docs/cdc-policy-distinguishing-public-health-research-nonresearch.pdf. Accessed March 31, 2014.
18. U.S. Department of Health & Human Services (HHS). Protection of Human Subjects, 45 CFR § 46 [HHS Web site]. July 14, 2009. Available at: http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.html. Accessed March 31, 2014.
19. Gratrix J, Bergman J, Egan C, et al. Retrospective review of pharyngeal gonorrhea treatment failures in Alberta, Canada. Sex Trans Dis 2013; 40: 877-879.
20. Rodgers S, Murgatroyd M, Perez K, et al. Challenges in implementing the new BASHH guidelines for the management of gonorrhea. Int J STD AIDS 2014; 25: 145-147.
21. Schachter J, Moncada J, Liska S, et al. Nucleic acid amplification tests in the diagnosis of chlamydial and gonococcal infections of the oropharynx and rectum in men who have sex with men. Sex Transm Dis 2008; 35: 637-642.
22. Page-Shafer KG, Graves A, Kent C, et al. Increased sensitivity of DNA amplification testing for the detection of pharyngeal gonorrhea in men who have sex with men. Clin Infect Dis 2002; 34: 173-176.
23. Alexander S, Ison C, Parry J, et al. Self-taken pharyngeal and rectal swabs are appropriate for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae in asymptomatic men who have sex with men. Sex Transm Dis 2008; 84: 488-492.
24. Rotblatt H, Montoya JA, Plant A, et al. There is no place like home - First-year use of the I Know home testing program for chlamydia and gonorrhea. Am J Public Health 2013; 103: 1376-1380.
25. Barbee L, Dombrowski J, Kerani R, et al. Introduction of extragenital self-obtained nucleic acid amplification tests (NAAT) for gonorrhea and chlamydial infection in MSM in an STD clinic. Presented at: 8th National STD Prevention Conference [D7.4]; 2012; Minneapolis.
26. Metzger DS, Koblin B, Turner C, et al. Randomized controlled trial of audio computer-assisted self-interviewing: utility and acceptability in longitudinal studies. HIVNET Vaccine Preparedness Study Protocol Team. Am J Epidemiol 2000; 152: 99-106.
27. Klein EJ, Fisher LS, Chow AW, et al. Anorectal gonococcal infection. Ann Intern Med 1977; 86: 340-346.
28. Bro Jorgensen A, Jensen T. Gonococcal pharyngeal infections. Report of 110 cases. Br J Vener Dis. 1973; 49: 491-499.